Synthetic Vape Deadlines Detailed
FDA lays out compliance timeline for flavored ENDS with lab-derived nicotine
MELBOURNE, Florida – With products containing synthetic nicotine now under the authority of the U.S. Food and Drug Administration (FDA), retailers selling flavored vaping devices containing lab-derived nicotine face uncertainty over whether or not what they’re selling is legal.
FDA’s new authority over these products began on March 15, 2022, when President Joe Biden signed a $1.5 trillion omnibus spending bill to fund the federal government through September of this year. According to the Washington, D.C.-based law firm, Keller and Heckman LLP, the bill, as passed, includes a provision expanding the definition of “tobacco product” in Section 201(rr) of the Federal Food, Drug, and Cosmetic Act (FDCA) to “any product made or derived from tobacco, or containing nicotine from any source, that is intended for human consumption.” 21 U.S.C. 321(rr).
Now that it is law, this provision closes the synthetic nicotine “loophole” and puts synthetic nicotine products under the FDA’s tobacco regulatory authority, the law firm said.
Enactment and enforcement of that authority will occur over a defined timeframe. First, the law became effective 30 days after the bill’s enactment, making April 14, 2022, the law’s “effective date”. Any synthetic nicotine product currently on the U.S. market as of April 14, 2022, can remain on the market only if they submit a Premarket Tobacco Product Application (PMTA), which are due 30 days later on May 14, 2022, i.e., the “Synthetic Nicotine PMTA Submission Deadline.”
Since May 14 is a Saturday, companies that are not planning to submit PMTAs via the Center for Tobacco Products’ electronic portal, can submit physical applications by 4:00 pm ET on Friday, May 13, 2022 (but note that any non-electronic PMTA submissions require a waiver from the FDA).